$1.82
+6.1%MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics. The company, through its LensAI platform and HYFT technology, it partners with pharmaceutical and biotechnology companies to drive de-risk drug development and unlock therapeutic possibilities. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.
Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.
Operating losses indicate the core business is unprofitable. Requires restructuring or revenue growth.
Net losses indicate the company is burning cash. Sustainability depends on path to profitability.
Margin squeeze alert: Healthy gross margins but weak operating margins suggest excessive operating expenses. Cost optimization could unlock significant value.
HYFT • NASDAQ
| MindWalk Holdings Corp. Income Statement | Apr 2025 | Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | Dec 2007 | Dec 2006 | Dec 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||||||||||||
24.5M | 24.5M | 20.7M | 19.4M | 17.9M | 14.1M | 10.9M | 5.4M | 2.6M | 1.9M | 1.8M | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
GROSS PROFIT | ||||||||||||||||||||
(11M) | (12.5M) | (9.1M) | (8.4M) | (6.4M) | (6M) | (5.6M) | (3M) | (1.2M) | (0.0) | (265.3K) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
13.5M | 12.1M | 11.6M | 11M | 11.5M | 8M | 5.3M | 2.5M | 1.4M | 1.6M | 1.5M | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
OPERATING INCOME | ||||||||||||||||||||
(25.7M) | (25.8M) | (37.2M) | (27.7M) | (15.7M) | (12.1M) | (11.5M) | (7.2M) | (2.8M) | (1.7M) | (65.9K) | (97.4K) | (81.2K) | (207.7K) | (261.4K) | (268.6K) | -70.5K | (615.6K) | (237.4K) | (205.5K) | |
(19M) | (19.1M) | (19M) | (18.1M) | (13.3M) | (9M) | (8.1M) | (5.8M) | (2M) | (1M) | (64.8K) | (94.7K) | (79.9K) | (205.5K) | (258.7K) | (265.1K) | (399.8K) | (611.7K) | (230.1K) | (202.6K) | |
(4.9M) | (4M) | (14.1M) | (7.7M) | (2M) | (446.3K) | (485.8K) | (509.2K) | (660.4K) | (302.8K) | (621.6K) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
-12.2M | -13.8M | -25.6M | -16.7M | -4.2M | -4.1M | -6.5M | -4.5M | -1.4M | 242.6K | -37.2K | -97.6K | -81.3K | -208K | -265K | -295K | -402.9K | -1.2M | -417K | -399.7K | |
PRE-TAX INCOME | ||||||||||||||||||||
(293K) | (19K) | (30K) | (85K) | (863K) | (1.4M) | (1.3M) | (255.8K) | (16.2K) | (9.3K) | (338.0) | (120.0) | (149.0) | (264.0) | (3.5K) | (26.1K) | (393.0) | (0.0) | (3K) | (50.2K) | |
-293K | 4K | 92K | 194K | -581K | -1.4M | -1.3M | -183K | -16.2K | -9.3K | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -13.4K | 8.3K | 0.0 | 11.5K | -6.1K | |
(1.8M) | (2.6M) | (4.1M) | (1.9M) | (475K) | (2.7M) | -3.3M | (256.5K) | (170.5K) | (332.6K) | (1K) | (2.7K) | (11.8K) | (2.2K) | (162.8K) | (1.1M) | (61.5K) | (0.0) | (237.4K) | (205.5K) | |
-22.1M | -14.9M | -2.1M | 825K | -1.8M | -1.5M | -1.4M | -132K | -4.1M | 221.2K | -25.1K | 167K | -14.5K | -67.7K | -5M | -1.1M | -70.2K | 130.8K | 11.5K | -6.1K | |
-34.3M | -28.7M | -27.8M | -15.8M | -6M | -5.3M | -7.6M | -5.1M | -5.5M | 242.6K | 344.1K | 69.4K | -95.8K | -276K | -5.3M | -1.4M | -473.1K | -1.1M | -405K | -405.8K | |
NET INCOME | ||||||||||||||||||||
-4M | -2.6M | -1.2M | (861K) | (1.3M) | -346K | (4.8K) | (109.7K) | -82.4K | (91.6K) | (338.0) | (120.0) | (149.0) | (264.0) | (0.0) | -394K | (0.0) | -336K | (0.0) | -572.3K | |
-30.2M | -26.1M | -26.6M | -16.7M | -7.3M | -4.9M | -7.6M | -5.2M | -5.4M | 151K | -62.3K | 69.4K | -95.8K | -276K | -5.3M | -991K | -473.1K | -757K | -405K | 166.5K |
HYFT - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
6-K 6-K 2025 Q4 Q4 | December 15, 2025 | October 31, 2025 | 2025 | |
6-K 6-K 2025 Q4 Q4 | December 15, 2025 | December 15, 2025 | 2025 | |
6-K 6-K 2025 Q4 Q4 | December 08, 2025 | December 08, 2025 | 2025 | |
6-K 6-K 2025 Q4 Q4 | November 13, 2025 | November 13, 2025 | 2025 | |
6-K 6-K 2025 Q4 Q4 | November 07, 2025 | November 07, 2025 | 2025 | |
6-K 6-K 2025 Q4 Q4 | November 06, 2025 | November 06, 2025 | 2025 | |
6-K 6-K 2025 Q4 Q4 | October 21, 2025 | October 21, 2025 | 2025 | |
6-K 6-K 2025 Q4 Q4 | October 21, 2025 | October 21, 2025 | 2025 | |
6-K 6-K 2025 Q4 Q4 | October 15, 2025 | October 15, 2025 | 2025 | |
6-K 6-K 2025 Q4 Q4 | October 14, 2025 | October 10, 2025 | 2025 |
Continue your HYFT research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.